Medical marijuana; expanding certain restrictions on certain advertising. Effective date.
SB191 amends Oklahoma’s medical marijuana advertising law to broaden the list of prohibited advertising content. The bill keeps the existing ban on deceptive, false, or misleading advertising and adds or clarifies restrictions on ads that promote overconsumption, claim marijuana has curative or therapeutic effects, suggest marijuana is safe or harmless, or market flavored products as healthier alternatives. It also expands the prohibition on child-appealing imagery and messaging by barring depictions of minors, toys, cartoons, flashing signs, flags, banners, tube men, and other designs that could especially attract children or persons under 18, including references to improved social status, physical appearance, or athletic performance. Discounts and coupons for medical marijuana products are also prohibited in advertising.
The bill would amend 63 O.S. Section 427.21, which governs medical marijuana advertising restrictions, and would update the statutory reference to reflect the new law. It would also add a new signage requirement for commercial grower licensees, requiring perimeter signage with specified dimensions, font size, and content including the business name, address, phone number, and license number, subject to county and local rules. Failure to post the required signage within 60 days after license renewal could result in immediate revocation of the commercial grower license, and temporary license holders would need to comply before prelicensure inspection. The measure is set to take effect November 1, 2025.
Based on the bill text and the absence of recorded committee debate or votes, the overall posture appears regulatory and restrictive rather than controversial on its face. The bill is framed as a consumer-protection and youth-protection measure, suggesting support from lawmakers concerned about marketing practices in the medical marijuana industry. No formal vote history or transcript is available here to show opposition or support, so the public sentiment cannot be measured directly from proceedings.
The main points of potential contention are the expanded limits on advertising and the strict enforcement mechanism for commercial grower signage. Medical marijuana businesses may view the bill as burdensome because it further restricts promotional practices, bans discounts and coupons, and imposes detailed signage requirements with license-revocation consequences for noncompliance. Supporters are likely to argue that these provisions reduce misleading claims, prevent youth-targeted marketing, and improve transparency about licensed grow operations. No specific committee objections or negotiated compromises are available in the provided materials.